Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 81,688 shares at $50.35 ($4.1M) on 2020-03-04, disclosed to the SEC on 2020-03-05.
Seasonal sale ($4.1M) by President and CEO — this insider has traded CCXI in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.35 | 40,844 | $2.1M | 50.0% |
| 2 | $50.35 | 40,844 | $2.1M | 50.0% |
| Total | $50.35 avg | 81,688 | $4.1M | 100% |
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |